Pages with the fewest revisions

Showing below up to 50 results in range #51 to #100.

51. Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance (1 revision)
52. A comparative genomic approach to decipher the mutations associated with Nipah viral human isolates from southeast Asia (1 revision)
53. The Genetic Diversity of Nipah Virus Across Spatial Scales (1 revision)
54. Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy (1 revision)
55. Bats Without Borders: Long-Distance Movements and Implications for Disease Risk Management (1 revision)
56. Assessing the risk of Nipah virus establishment in Australian flying-foxes (1 revision)
57. Nipah Virus in the Fruit Bat Pteropus vampyrus in Sumatera, Indonesia (1 revision)
58. Infectious Causes of Acute Encephalitis Syndrome in India – Decadal Change and the Way Forward (1 revision)
59. Nipah Virus Infection Outbreak with Nosocomial and Corpse-to-Human Transmission, Bangladesh (1 revision)
60. Navigating Nipah virus: Insights, challenges, and recommendations (1 revision)
61. Concern over Nipah virus cases amidst the COVID‐19 pandemic in India (1 revision)
62. Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases (1 revision)
63. Nipah and Hendra Viruses: Deadly Zoonotic Paramyxoviruses with the Potential to Cause the Next Pandemic (1 revision)
64. Full genome sequence of Nipah virus from an outbreak in India (1 revision)
65. Development of Nipah virus-specific IgM & IgG ELISA for screening human serum samples (1 revision)
66. Experimental Infection of Syrian Hamsters With Aerosolized Nipah Virus (1 revision)
67. Super-spreaders of novel coronaviruses that cause SARS, MERS and COVID-19: a systematic review (1 revision)
68. Human Exposure to Bats, Rodents and Monkeys in Bangladesh (1 revision)
69. Trends in Bacterial Pathogens of Bats: Global Distribution and Knowledge Gaps (1 revision)
70. Flying-Fox Species Density - A Spatial Risk Factor for Hendra Virus Infection in Horses in Eastern Australia (1 revision)
71. Henipavirus Encephalitis: Recent Developments and Advances (1 revision)
72. Outbreak of Henipavirus Infection, Philippines, 2014 (1 revision)
73. Structural and functional analysis of the Nipah virus polymerase complex (1 revision)
74. Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report (1 revision)
75. Nipah Outbreak: Is it the beginning of another pandemic in the era of COVID-19 and Zika (1 revision)
76. Henipaviruses—A constant threat to livestock and humans (1 revision)
77. An Immunoinformatics Prediction of Novel Multi-Epitope Vaccines Candidate Against Surface Antigens of Nipah Virus (1 revision)
78. Characterization of Nipah Virus from Outbreaks in Bangladesh, 2008–2010 (1 revision)
79. Genomic characterization, transcriptome analysis, and pathogenicity of the Nipah virus (Indian isolate) (1 revision)
80. Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters (1 revision)
81. Evolution of Nipah Virus Infection: Past, Present, and Future Considerations (1 revision)
82. Detection of Nipah virus in Pteropus medius in 2019 outbreak from Ernakulam district, Kerala, India (1 revision)
83. Seroprevalence of Nipah virus and related paramyxoviruses in native frugivorous bats, Luzon, Philippines (1 revision)
84. Infectome analysis of bat kidneys from Yunnan province, China, reveals novel henipaviruses related to Hendra and Nipah viruses and prevalent bacterial and eukaryotic microbes (1 revision)
85. Antibody response in symptomatic & asymptomatic Nipah virus cases from Kerala, India (1 revision)
86. Hendra and Nipah viruses: different and dangerous (1 revision)
87. A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses (1 revision)
88. Advancing the frontiers: Revolutionary control and prevention paradigms against Nipah virus (1 revision)
89. Clinical Medicine 2022 Vol 22, No 4: 348–52 - Review of Nipah virus encephalitis (1 revision)
90. Tackling a global epidemic threat: Nipah surveillance in Bangladesh, 2006–2021 (1 revision)
91. A Novel Model of Lethal Hendra Virus Infection in African Green Monkeys and the Effectiveness of Ribavirin Treatment (1 revision)
92. Functional and antigenic landscape of the Nipah virus receptor-binding protein (1 revision)
93. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge (1 revision)
94. Vertical Transfer of Humoral Immunity against Nipah Virus: A Novel Evidence from Bangladesh (1 revision)
95. Serological and molecular analysis of henipavirus infections in synanthropic fruit bat and rodent populations in the Centre and North regions of Cameroon (2018–2020) (1 revision)
96. Major bat-borne zoonotic viral epidemics in Asia and Africa: A systematic review and meta-analysis (1 revision)
97. The Ecology of Nipah Virus in Bangladesh: A Nexus of Land-Use Change and Opportunistic Feeding Behavior in Bats (1 revision)
98. Bot Test Page (1 revision)
99. Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics (1 revision)
100. Nipah: The looming post-covid pandemic (1 revision)